EP 1100485 A1 20010523 - SUBSTITUTED ANILIDE COMPOUNDS AND METHODS
Title (en)
SUBSTITUTED ANILIDE COMPOUNDS AND METHODS
Title (de)
SUBSTITUIERTE ANILIDVERBINDUNGEN UND DAMIT VERBUNDENE METHODEN
Title (fr)
COMPOSES D'ANILIDE SUBSTITUES ET METHODES ASSOCIEES
Publication
Application
Priority
- US 9917121 W 19990728
- US 9440698 P 19980728
- US 13415799 P 19990514
Abstract (en)
[origin: WO0006146A1] This invention relates to substituted anilide compounds which are modulators, agonists or antagonists, of the CCR5 receptor. In addition, this invention relates to the treatment and prevention of disease states mediated by CCR5.
IPC 1-7
IPC 8 full level
A61K 31/00 (2006.01); C07D 215/38 (2006.01); A61K 31/167 (2006.01); A61K 31/18 (2006.01); A61K 31/426 (2006.01); A61K 31/438 (2006.01); A61K 31/4427 (2006.01); A61K 31/445 (2006.01); A61K 31/4453 (2006.01); A61K 31/47 (2006.01); A61K 31/498 (2006.01); A61K 31/538 (2006.01); A61P 1/00 (2006.01); A61P 11/06 (2006.01); A61P 17/06 (2006.01); A61P 19/02 (2006.01); A61P 29/00 (2006.01); A61P 37/00 (2006.01); A61P 37/06 (2006.01); A61P 37/08 (2006.01); C07C 233/75 (2006.01); C07C 235/42 (2006.01); C07C 235/56 (2006.01); C07C 235/84 (2006.01); C07C 237/40 (2006.01); C07C 251/48 (2006.01); C07C 311/39 (2006.01); C07C 317/44 (2006.01); C07D 211/14 (2006.01); C07D 215/06 (2006.01); C07D 241/54 (2006.01); C07D 265/36 (2006.01); C07D 277/20 (2006.01); C07D 277/46 (2006.01); C07D 277/56 (2006.01); C07D 295/092 (2006.01); C07D 401/12 (2006.01); C07D 491/10 (2006.01); C07D 491/107 (2006.01)
CPC (source: EP KR)
A61K 31/00 (2013.01 - EP); A61K 31/165 (2013.01 - KR); A61K 31/167 (2013.01 - EP); A61K 31/18 (2013.01 - EP); A61K 31/426 (2013.01 - EP); A61K 31/438 (2013.01 - EP); A61K 31/445 (2013.01 - EP); A61K 31/47 (2013.01 - EP); A61K 31/498 (2013.01 - EP); A61K 31/538 (2013.01 - EP); A61K 31/5383 (2013.01 - EP); A61P 1/00 (2018.01 - EP); A61P 7/00 (2018.01 - EP); A61P 11/06 (2018.01 - EP); A61P 17/00 (2018.01 - EP); A61P 17/06 (2018.01 - EP); A61P 19/02 (2018.01 - EP); A61P 29/00 (2018.01 - EP); A61P 37/00 (2018.01 - EP); A61P 37/06 (2018.01 - EP); A61P 37/08 (2018.01 - EP); A61P 43/00 (2018.01 - EP); C07C 233/75 (2013.01 - EP); C07C 235/42 (2013.01 - EP); C07C 235/56 (2013.01 - EP); C07C 235/84 (2013.01 - EP); C07C 237/40 (2013.01 - EP); C07C 251/48 (2013.01 - EP); C07C 311/39 (2013.01 - EP); C07C 317/44 (2013.01 - EP); C07D 215/06 (2013.01 - EP); C07D 241/54 (2013.01 - EP); C07D 265/36 (2013.01 - EP); C07D 277/56 (2013.01 - EP); C07D 295/088 (2013.01 - EP); C07D 491/10 (2013.01 - EP)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0006146 A1 20000210; WO 0006146 A9 20000803; AU 5239299 A 20000221; BR 9912406 A 20010424; CA 2338764 A1 20000210; CN 1310621 A 20010829; EP 1100485 A1 20010523; EP 1100485 A4 20040609; HU P0102752 A2 20011228; HU P0102752 A3 20021128; IL 141028 A0 20020210; JP 2002521436 A 20020716; KR 20010074779 A 20010809; NO 20010446 D0 20010126; NO 20010446 L 20010126; PL 345713 A1 20020102; TR 200100267 T2 20010921
DOCDB simple family (application)
US 9917121 W 19990728; AU 5239299 A 19990728; BR 9912406 A 19990728; CA 2338764 A 19990728; CN 99809041 A 19990728; EP 99937589 A 19990728; HU P0102752 A 19990728; IL 14102899 A 19990728; JP 2000562001 A 19990728; KR 20017001173 A 20010127; NO 20010446 A 20010126; PL 34571399 A 19990728; TR 200100267 T 19990728